Literature DB >> 9256421

Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53.

Y Wu1, H Huang, Z Miner, M Kulesz-Martin.   

Abstract

The mouse p53 protein generated by alternative splicing (p53as) has amino acid substitutions at its C terminus that result in constitutively active sequence-specific DNA binding (active form), whereas p53 protein itself binds inefficiently (latent form) unless activated by C-terminal modification. Exogenous p53as expression activated transcription of reporter plasmids containing p53 binding sequences and inhibited growth of mouse and human cells lacking functional endogenous p53. Inducible p53as in stably transfected p53 null fibroblasts increased p21(WAF1/Cip-1/Sdi) and decreased bcl-2 protein steady-state levels. Endogenous p53as and p53 proteins differed in response to cellular DNA damage. p53 protein was induced transiently in normal keratinocytes and fibroblasts whereas p53as protein accumulation was sustained in parallel with induction of p21(WAF1/Cip-1/Sdi) protein and mRNA, in support of p53as transcriptional activity. Endogenous p53 and p53as proteins in epidermal tumor cells responded to DNA damage with different kinetics of nuclear accumulation and efficiencies of binding to a p53 consensus DNA sequence. A model is proposed in which C-terminally distinct p53 protein forms specialize in functions, with latent p53 forms primarily for rapid non-sequence-specific binding to sites of DNA damage and active p53 forms for sustained regulation of transcription and growth.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256421      PMCID: PMC22993          DOI: 10.1073/pnas.94.17.8982

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  74 in total

1.  A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.

Authors:  J Bargonetti; J J Manfredi; X Chen; D R Marshak; C Prives
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

2.  p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer.

Authors:  G Bakalkin; T Yakovleva; G Selivanova; K P Magnusson; L Szekely; E Kiseleva; G Klein; L Terenius; K G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

3.  Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells.

Authors:  M F Kulesz-Martin; B Lisafeld; H Huang; N D Kisiel; L Lee
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

4.  Sequence-specific transcriptional activation is essential for growth suppression by p53.

Authors:  J A Pietenpol; T Tokino; S Thiagalingam; W S el-Deiry; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

5.  p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation.

Authors:  A R Clarke; S Gledhill; M L Hooper; C C Bird; A H Wyllie
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

6.  The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.

Authors:  N P Pavletich; K A Chambers; C O Pabo
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

7.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

8.  Both viral (adenovirus E1B) and cellular (hsp 70, p53) components interact with centrosomes.

Authors:  C R Brown; S J Doxsey; E White; W J Welch
Journal:  J Cell Physiol       Date:  1994-07       Impact factor: 6.384

9.  Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants.

Authors:  T D Halazonetis; A N Kandil
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

10.  Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

Authors:  K Ory; Y Legros; C Auguin; T Soussi
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

View more
  7 in total

1.  Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene.

Authors:  M Laverdière; J Beaudoin; A Lavigueur
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

2.  Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas.

Authors:  M J Schwerer; A Sailer; K Kraft; K Baczako; H Maier
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

3.  Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation.

Authors:  M Kapoor; G Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

4.  p53 Isoforms: An Intracellular Microprocessor?

Authors:  Marie P Khoury; Jean-Christophe Bourdon
Journal:  Genes Cancer       Date:  2011-04

5.  p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes.

Authors:  V A Tron; M J Trotter; L Tang; M Krajewska; J C Reed; V C Ho; G Li
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

6.  p53-mediated regulation of proliferating cell nuclear antigen expression in cells exposed to ionizing radiation.

Authors:  J Xu; G F Morris
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

7.  Changes in the expression of splicing factor transcripts and variations in alternative splicing are associated with lifespan in mice and humans.

Authors:  Benjamin P Lee; Luke C Pilling; Florence Emond; Kevin Flurkey; David E Harrison; Rong Yuan; Luanne L Peters; George A Kuchel; Luigi Ferrucci; David Melzer; Lorna W Harries
Journal:  Aging Cell       Date:  2016-06-30       Impact factor: 9.304

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.